Quick Overview: Tomas G. Neilan, MD, MPH, MRCPI, FACC Director, Cardio-Oncology Program; co-Director, Graham Collins, MA, MBBS, MRCP, FRCPath, DPhil, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, discusses ... Icro Meattini, MD, University of Florence, Florence, Italy, talks on the risk of cancer therapy-related
Cardiac Toxicities Among Patients Treated - Detailed Overview & Context
Tomas G. Neilan, MD, MPH, MRCPI, FACC Director, Cardio-Oncology Program; co-Director, Graham Collins, MA, MBBS, MRCP, FRCPath, DPhil, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, discusses ... Icro Meattini, MD, University of Florence, Florence, Italy, talks on the risk of cancer therapy-related LURIE CANCER CENTER & HEMATOLOGY/ONCOLOGY GRAND ROUNDS Friday, March 4, 2022 Jonathan Strauss, MD Vice ... Brian Colwell Jensen, MD, will introduce the audience to potential Han Zhu, MD, Stanford University, Standford, CA, discusses risk factors for cardiotoxic events
Gerard Walls, MB MRCP MSc FRCR, Queens University Dr. Paul Cottu, oncologist at Institut Curie, Paris, FR provides an overview of breast cancer therapies with associated ... Immune checkpoints are integral to the immune system, ensuring that there is no overactivation once an immune response is ... This JCO Podcast provides observations and commentary on the JCO article “Therapy-Related Lydia Scarfò, MD, Vita-Salute San Raffaele University & IRCCS San Raffaele Scientific Institute, Milan, Italy, discussess ... Chemotherapy is the most important of cancer treatments, affirms Dr. Alvaro Gomez, Cardiologist with Miami
Dr Chris Plummer talks to ecancer at SIOG 2017 Lisa Leypoldt, MD, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, comments on the
